Search

everythinglearnresearchcommunity

for

Search:↓

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

Hair loss from mood stabilizers is common but can be managed without stopping the medication.

Certain microRNAs are more common in balding areas and might be involved in male pattern baldness.

Male pattern baldness may be caused by factors like poor blood circulation, scalp tension, stress, and hormonal imbalances, but the exact causes are still unclear.

Cancer survivors often experience worse skin problems from treatment than expected, and working with dermatologists could help improve their condition.

Better hair loss models needed for research.

Etanercept, a psoriasis treatment, caused hair loss in a patient.

Different types of hair loss have unique features under a microscope, but a doctor's exam is important for accurate diagnosis.

Sebum production varies by individual and is influenced by age, gender, and hormones, affecting skin and hair health.

A woman developed hair loss after starting a treatment with adalimumab, suggesting this medication might cause hair loss.

The document concludes that Syndromes of Severe Insulin Resistance are rare disorders with limited treatment options.

Platelet lysate is a promising, cost-effective option for regenerative medicine with potential clinical applications.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

Hormones and genetics play key roles in male and female baldness, which can affect mental health and may be linked to other health issues.

Melanoma development can be linked to the breakdown of skin's melanin-producing units.

The conclusion is that treatments like finasteride and minoxidil can prevent baldness progression and improve hair density, but more research is needed on other therapies.

Various treatments exist for hair loss, but more research is needed for better options.

More plasma leptin means higher baldness risk in men.

Telogen Effluvium is a common hair loss condition, particularly in women, with no specific FDA-approved treatment, and recovery can take up to 18 months.

Chemotherapy can cause skin side effects that affect patients' lives, but they can be managed to avoid interrupting cancer treatment.

Alopecia areata causes hair loss with varied treatment responses and frequent relapses.

Hair loss from Telogen Effluvium can be managed by treating the underlying cause and may improve with treatments like minoxidil.

Lasers and light treatments are now the most common ways to remove hair.

TNF-alpha inhibitors can cause various immune-related skin issues.

Male pattern baldness involves three mechanisms and finasteride can help reverse it.

The document concludes that computational models are useful for understanding immune responses and could improve cancer immunotherapy.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

Menopause can lead to skin and hair problems due to hormonal changes, but hormone replacement therapy might help slow these effects.

Hair loss in men is common, treatable, but not curable.

Smoking harms the skin, causing early aging and increasing cancer risk, but stopping smoking can improve skin health.